NCT03742258 2025-06-18Combination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Diffuse Large B Cell LymphomaNorthwestern UniversityPhase 1 Completed12 enrolled 13 charts
NCT03357627 2023-02-08A Study of TAK-659 in Combination With Venetoclax for Adult Participants With Previously Treated Non-Hodgkin LymphomaCalithera Biosciences, IncPhase 1 Completed43 enrolled